{"id":22201,"date":"2026-07-15T23:57:25","date_gmt":"2026-07-16T03:57:25","guid":{"rendered":"https:\/\/divulguems.com.br\/?p=22201"},"modified":"2026-07-15T23:57:25","modified_gmt":"2026-07-16T03:57:25","slug":"sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv","status":"publish","type":"post","link":"https:\/\/divulguems.com.br\/?p=22201","title":{"rendered":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV"},"content":{"rendered":"<\/p>\n<p><a class=\"\" href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-07\/sus-adquire-tecnologia-para-produzir-principal-rem%C3%A9dio-contra-o-hiv\"><br \/>\n                    <img decoding=\"async\" src=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" alt=\"Logo Ag\u00eancia Brasil\"><br \/>\n\t\t\t\t<\/a><\/p>\n<p>A Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz)\u00a0concluiu a transfer\u00eancia de tecnologia para produzir o principal rem\u00e9dio utilizado para o tratamento do HIV no Brasil, o antiretroviral dolutegravir, que \u00e9 distribu\u00eddo gratuitamente pelo Sistema \u00danico de Sa\u00fade (SUS). <strong>Atualmente, mais de 770 mil pessoas vivendo com HIV fazem uso do medicamento no pa\u00eds<\/strong>.<img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.png?id=1696742&#038;o=rss\"><img decoding=\"async\" src=\"https:\/\/agenciabrasil.ebc.com.br\/ebc.gif?id=1696742&#038;o=rss\"><\/p>\n<p>O medicamento foi desenvolvido pela ViiV Healthcare, empresa de pesquisa para preven\u00e7\u00e3o e tratamento para HIV pertencente \u00e0 biofarmac\u00eautica GSK.<strong> Em 2020, ambas assinaram um contrato com o Instituto de Tecnologia em F\u00e1rmacos (Farmanguinhos) da Fiocruz\u00a0para nacionalizar progressivamente a produ\u00e7\u00e3o do rem\u00e9dio\u00a0e distribu\u00ed-lo ao SUS<\/strong>.<\/p>\n<\/p>\n<h3>Not\u00edcias relacionadas:<\/h3>\n<ul>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-07\/cientistas-da-fiocruz-podem-produzir-vacina-completa-contra-malaria\">Cientistas da Fiocruz podem produzir vacina completa contra a mal\u00e1ria.<\/a><\/li>\n<li><a href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-07\/fiocruz-aponta-queda-da-sindrome-respiratoria-aguda-grave-no-pais\">Fiocruz aponta queda da S\u00edndrome Respirat\u00f3ria Aguda Grave no pa\u00eds.<\/a><\/li>\n<\/ul>\n<p>Desde ent\u00e3o, Farmanguinhos vem realizando investimentos para adaptar sua planta fabril, adquirir novos equipamentos, capacitar seus profissionais e promover\u00a0estrutura\u00e7\u00e3o t\u00e9cnica, regulat\u00f3ria e operacional para garantir a internaliza\u00e7\u00e3o da produ\u00e7\u00e3o. Este processo acaba de ser conclu\u00eddo, e <strong>o in\u00edcio do fornecimento ao SUS\u00a0depende apenas da libera\u00e7\u00e3o da Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa)<\/strong>.<\/p>\n<p>Desde 2022, o instituto da Fiocruz j\u00e1 faz a distribui\u00e7\u00e3o para o SUS dos rem\u00e9dios produzidos em f\u00e1bricas da GSK. Mais de 739 milh\u00f5es de c\u00e1psulas j\u00e1 foram fornecidas para a sa\u00fade p\u00fablica desta forma. Em 2025, Farmanguinhos tamb\u00e9m assumiu as an\u00e1lises laboratoriais de controle de qualidade do medicamento.\u00a0<\/p>\n<p><strong>Tr\u00eas lotes do rem\u00e9dio j\u00e1 foram fabricados e validados pelo instituto\u00a0e poder\u00e3o ser distribu\u00eddos para o SUS, assim que a libera\u00e7\u00e3o da Anvisa for expedida.<\/strong> Paralelamente, o instituto trabalha na valida\u00e7\u00e3o da metologia anal\u00edtica do ingrediente farmac\u00eautico ativo.\u00a0<\/p>\n<p><strong>O acordo de transfer\u00eancia de tecnologia inclui mais uma etapa: a internaliza\u00e7\u00e3o da produ\u00e7\u00e3o do dolutegravir em combina\u00e7\u00e3o com outra subst\u00e2ncia, a lamivudina<\/strong>. Esse formato tamb\u00e9m \u00e9 distribu\u00eddo pelo SUS. A expectativa \u00e9 que essa produ\u00e7\u00e3o comece a ser feita por Farmaguinhos no ano que vem.\u00a0<\/p>\n<h2>Medicamento recomendado pela OMS<\/h2>\n<p>Dolutegravir \u00e9 um dos principais medicamentos utilizados no tratamento para HIV em todo o mundo. Ele age inibindo a enzima integrase, o que impede a replica\u00e7\u00e3o do v\u00edrus dentro das c\u00e9lulas de defesa do organismo. Al\u00e9m de ser altamente eficaz, reduzindo a carga viral a n\u00edveis indetect\u00e1veis, ele melhora a imunidade e impede a progress\u00e3o para a AIDS, com poucos efeitos colaterais.<\/p>\n<p>Em 2019, a Organiza\u00e7\u00e3o Mundial da Sa\u00fade (OMS) passou a recomendar o medicamento como op\u00e7\u00e3o preferencial para tratamento de primeira e segunda linha em todas as popula\u00e7\u00f5es, incluindo mulheres gr\u00e1vidas e pessoas com potencial para engravidar.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz)\u00a0concluiu a transfer\u00eancia de tecnologia para produzir o principal rem\u00e9dio utilizado para o tratamento do HIV no Brasil, o antiretroviral dolutegravir, que \u00e9 distribu\u00eddo gratuitamente pelo Sistema \u00danico de Sa\u00fade (SUS). Atualmente, mais de 770 mil pessoas vivendo com HIV fazem uso do medicamento no pa\u00eds. O medicamento foi desenvolvido pela [&hellip;]<\/p>\n","protected":false},"author":123,"featured_media":22202,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[11],"tags":[],"class_list":["post-22201","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude-e-bem-estar"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV - Divulgue MS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/divulguems.com.br\/?p=22201\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV\" \/>\n<meta property=\"og:description\" content=\"A Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz)\u00a0concluiu a transfer\u00eancia de tecnologia para produzir o principal rem\u00e9dio utilizado para o tratamento do HIV no Brasil, o antiretroviral dolutegravir, que \u00e9 distribu\u00eddo gratuitamente pelo Sistema \u00danico de Sa\u00fade (SUS). Atualmente, mais de 770 mil pessoas vivendo com HIV fazem uso do medicamento no pa\u00eds. O medicamento foi desenvolvido pela [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/divulguems.com.br\/?p=22201\" \/>\n<meta property=\"og:site_name\" content=\"Divulgue MS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/portalinfocobrasil\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-16T03:57:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg\" \/>\n<meta name=\"author\" content=\"Tamara Freire - reporter da Agencia Brasil\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tamara Freire - reporter da Agencia Brasil\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201\"},\"author\":{\"name\":\"Tamara Freire - reporter da Agencia Brasil\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/person\\\/ad732574b8ae69f7d1d8d9ac839635e7\"},\"headline\":\"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV\",\"datePublished\":\"2026-07-16T03:57:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201\"},\"wordCount\":476,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg\",\"articleSection\":[\"Sa\u00fade e Bem-Estar\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201\",\"name\":\"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV - Divulgue MS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg\",\"datePublished\":\"2026-07-16T03:57:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/divulguems.com.br\\\/?p=22201\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#primaryimage\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg\",\"contentUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg\",\"width\":1600,\"height\":800,\"caption\":\"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/?p=22201#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/divulguems.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#website\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/\",\"name\":\"Portal Infoco Brasil\",\"description\":\"L\u00edder de audi\u00eancia.\",\"publisher\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/divulguems.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#organization\",\"name\":\"Portal Infoco Brasil\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/LOGO-PNG-AZUL.png\",\"contentUrl\":\"https:\\\/\\\/divulguems.com.br\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/LOGO-PNG-AZUL.png\",\"width\":1166,\"height\":475,\"caption\":\"Portal Infoco Brasil\"},\"image\":{\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/portalinfocobrasil\",\"https:\\\/\\\/www.instagram.com\\\/portalinfocobrasil\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/divulguems.com.br\\\/#\\\/schema\\\/person\\\/ad732574b8ae69f7d1d8d9ac839635e7\",\"name\":\"Tamara Freire - reporter da Agencia Brasil\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fdc16eba3e3df2e7f99d891d268be546eeca2ea98f837509775832d16bd3f593?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fdc16eba3e3df2e7f99d891d268be546eeca2ea98f837509775832d16bd3f593?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fdc16eba3e3df2e7f99d891d268be546eeca2ea98f837509775832d16bd3f593?s=96&d=mm&r=g\",\"caption\":\"Tamara Freire - reporter da Agencia Brasil\"},\"url\":\"https:\\\/\\\/divulguems.com.br\\\/?author=123\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV - Divulgue MS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/divulguems.com.br\/?p=22201","og_locale":"pt_BR","og_type":"article","og_title":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV","og_description":"A Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz)\u00a0concluiu a transfer\u00eancia de tecnologia para produzir o principal rem\u00e9dio utilizado para o tratamento do HIV no Brasil, o antiretroviral dolutegravir, que \u00e9 distribu\u00eddo gratuitamente pelo Sistema \u00danico de Sa\u00fade (SUS). Atualmente, mais de 770 mil pessoas vivendo com HIV fazem uso do medicamento no pa\u00eds. O medicamento foi desenvolvido pela [&hellip;]","og_url":"https:\/\/divulguems.com.br\/?p=22201","og_site_name":"Divulgue MS","article_publisher":"https:\/\/www.facebook.com\/portalinfocobrasil","article_published_time":"2026-07-16T03:57:25+00:00","og_image":[{"url":"https:\/\/cdn.jsdelivr.net\/gh\/sergiosdlima\/assets-ebc@1.0.0\/abr\/assets\/images\/logo-agenciabrasil.svg","type":"","width":"","height":""}],"author":"Tamara Freire - reporter da Agencia Brasil","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Tamara Freire - reporter da Agencia Brasil","Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/divulguems.com.br\/?p=22201#article","isPartOf":{"@id":"https:\/\/divulguems.com.br\/?p=22201"},"author":{"name":"Tamara Freire - reporter da Agencia Brasil","@id":"https:\/\/divulguems.com.br\/#\/schema\/person\/ad732574b8ae69f7d1d8d9ac839635e7"},"headline":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV","datePublished":"2026-07-16T03:57:25+00:00","mainEntityOfPage":{"@id":"https:\/\/divulguems.com.br\/?p=22201"},"wordCount":476,"commentCount":0,"publisher":{"@id":"https:\/\/divulguems.com.br\/#organization"},"image":{"@id":"https:\/\/divulguems.com.br\/?p=22201#primaryimage"},"thumbnailUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/07\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg","articleSection":["Sa\u00fade e Bem-Estar"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/divulguems.com.br\/?p=22201#respond"]}]},{"@type":"WebPage","@id":"https:\/\/divulguems.com.br\/?p=22201","url":"https:\/\/divulguems.com.br\/?p=22201","name":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV - Divulgue MS","isPartOf":{"@id":"https:\/\/divulguems.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/divulguems.com.br\/?p=22201#primaryimage"},"image":{"@id":"https:\/\/divulguems.com.br\/?p=22201#primaryimage"},"thumbnailUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/07\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg","datePublished":"2026-07-16T03:57:25+00:00","breadcrumb":{"@id":"https:\/\/divulguems.com.br\/?p=22201#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/divulguems.com.br\/?p=22201"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/divulguems.com.br\/?p=22201#primaryimage","url":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/07\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg","contentUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2026\/07\/22201-sus-adquire-tecnologia-para-produzir-principal-remedio-contra-o-hiv.jpg","width":1600,"height":800,"caption":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV"},{"@type":"BreadcrumbList","@id":"https:\/\/divulguems.com.br\/?p=22201#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/divulguems.com.br\/"},{"@type":"ListItem","position":2,"name":"SUS adquire tecnologia para produzir principal rem\u00e9dio contra o HIV"}]},{"@type":"WebSite","@id":"https:\/\/divulguems.com.br\/#website","url":"https:\/\/divulguems.com.br\/","name":"Portal Infoco Brasil","description":"L\u00edder de audi\u00eancia.","publisher":{"@id":"https:\/\/divulguems.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/divulguems.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/divulguems.com.br\/#organization","name":"Portal Infoco Brasil","url":"https:\/\/divulguems.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/divulguems.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2025\/04\/LOGO-PNG-AZUL.png","contentUrl":"https:\/\/divulguems.com.br\/wp-content\/uploads\/2025\/04\/LOGO-PNG-AZUL.png","width":1166,"height":475,"caption":"Portal Infoco Brasil"},"image":{"@id":"https:\/\/divulguems.com.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/portalinfocobrasil","https:\/\/www.instagram.com\/portalinfocobrasil"]},{"@type":"Person","@id":"https:\/\/divulguems.com.br\/#\/schema\/person\/ad732574b8ae69f7d1d8d9ac839635e7","name":"Tamara Freire - reporter da Agencia Brasil","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fdc16eba3e3df2e7f99d891d268be546eeca2ea98f837509775832d16bd3f593?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fdc16eba3e3df2e7f99d891d268be546eeca2ea98f837509775832d16bd3f593?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fdc16eba3e3df2e7f99d891d268be546eeca2ea98f837509775832d16bd3f593?s=96&d=mm&r=g","caption":"Tamara Freire - reporter da Agencia Brasil"},"url":"https:\/\/divulguems.com.br\/?author=123"}]}},"_links":{"self":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/posts\/22201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22201"}],"version-history":[{"count":0,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/posts\/22201\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=\/wp\/v2\/media\/22202"}],"wp:attachment":[{"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/divulguems.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}